Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
19 September 2014 09:28
A trial to find a vaccine against the Ebola virus is due to take place at Oxford University
A trial to find a vaccine for the deadly Ebola virus is due to begin - and a volunteer from the UK will become the first person to receive the experimental drug.
A total of 60 people are due to take part in the safety trial at the University of Oxford, which may offer hope to people in Guinea, Sierra Leone, Liberia and other West African nations where Ebola has so far killed nearly 2,500 people.
More than half of those infected with the virus (53%) have died from the disease, according to the World Health Organisation - which should serve as a reminder for people travelling to Africa to take out medical travel insurance before they depart.
The vaccine, which is part of the current trial at Oxford, has been developed by GlaxoSmithKline (GSK) and the US National Institute of Health. It is aimed at the "Zaire strand" of the virus which is among those found in West Africa.
Experts at Oxford University have emphasised that participants cannot get infected with Ebola as the drug only contains one benign protein found in the virus.
The vaccine will only be tested on healthy adults, and researchers will check for possible side-effects and the nature of the immune response. It has already been tested on animals, and early indications are that it can protect non-human primates from Ebola without significant side effects.
GSK is producing 10,000 extra doses of the vaccine while the trial takes place thanks to a £2.8 million funding boost from the Medical Research Council, the Wellcome Trust and the Department for International Development
If the Oxford trial is a success, the vaccine will be tested again in West Africa to ensure the research takes differences between populations into account.
22 February 2017
Hundreds of thousands of people with a potentially fatal genetic blood condition have yet to be diagnosed with the condition, a charity is warning.
21 February 2017
New technology to provide detailed scans of patients could improve the recovery of people suffering with liver cancer, scientists have said.
18 February 2017
At least 10 Britons have been injured in a speedboat accident off the icy coast of Norway.
17 February 2017
Comedian David Baddiel is trying to highlight the "epidemic" of dementia as a killer of older people in a new documentary.
16 February 2017
The public has spoken and the world's favourite cruises are being honoured by a top cruise review site.
15 February 2017
The collaborative #SkiSafe campaign has been relaunched in a bid to raise safety awareness among winter sports enthusiasts.
14 February 2017
A new "age defying" hormone could offer a breakthrough in preventing kidney and heart disease in people who suffer from diabetes.
11 February 2017
Patients needing new life-saving medication could have to wait two years after the UK leaves the EU, experts are warning.
10 February 2017
Families looking to take a cheap break in the upcoming half term are often sorely disappointed, however new research suggests Cyprus is the best destination for a well-priced trip.
09 February 2017
Europe remains the world's number one region as a travel destination - but tourism growth is slowing down, a travel industry report has said.
08 February 2017
A terminal cancer patient is determined to fulfil his dream of climbing Mount Everest, despite having just months to live.
07 February 2017
One third of holidaying families will opt for a British break this year, new research suggests.